Birdwatch Note
2022-08-24 19:41:55 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Christine Grady is Anthony Fauci’s spouse and the head of the Department of Bioethics at the NIH Clinical Center. However 1. The NIH is not a company. It is a government agency https://www.nih.gov/about-nih/who-we-are 2. No company “approves drugs for the FDA”. The FDA is a separate agency that approves drugs https://www.fda.gov/drugs/development-approval-process-drugs
Written by 1E9D60C6D4AE0895E007C4F746149AED
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1478028557070782474
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1562525630570582016
- noteId - 1562525630570582016
- participantId - 1E9D60C6D4AE0895E007C4F746149AED
- noteAuthorParticipantId -
- createdAtMillis - 1661370115307
- tweetId - 1478028557070782474
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Christine Grady is Anthony Fauci’s spouse and the head of the Department of Bioethics at the NIH Clinical Center. However 1. The NIH is not a company. It is a government agency https://www.nih.gov/about-nih/who-we-are 2. No company “approves drugs for the FDA”. The FDA is a separate agency that approves drugs https://www.fda.gov/drugs/development-approval-process-drugs
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-08-24 19:41:55 UTC (1661370115307) |
2022-08-25 03:40:04 UTC (1661398804057) |
CURRENTLY_RATED_HELPFUL | 2022-08-25 03:40:04 UTC (1661398804057) |
CURRENTLY_RATED_HELPFUL | 2022-08-25 03:40:04 UTC (1661398804057) |
CURRENTLY_RATED_HELPFUL | 55CDB0C1B5A58436987B00C63EBDD3980BF71CC3A30D4EE3BD4BA7D33AAEBCAD |
2022-08-24 19:41:55 UTC (1661370115307) |
2022-08-25 03:40:04 UTC (1661398804057) |
CURRENTLY_RATED_HELPFUL | 2022-08-25 03:40:04 UTC (1661398804057) |
CURRENTLY_RATED_HELPFUL | 2022-08-25 03:40:04 UTC (1661398804057) |
CURRENTLY_RATED_HELPFUL | 1E9D60C6D4AE0895E007C4F746149AED |
Note Ratings
rated at | rated by | |
2022-08-24 14:51:10 -0500 | 0A98F8DF5EDD42D0073EF5CBFAC32E6B41A3478D6689D5D7B6D72C74F37A2836 | Rating Details |
2022-08-25 07:18:49 -0500 | 0AB689C453F1E569091558B03440721F | Rating Details |
2022-08-24 14:46:53 -0500 | 0B683F53A71314B5B037053E967D8B7476EE62CEC7C245474E462A3294BE2995 | Rating Details |
2022-08-24 14:45:15 -0500 | 0C91900F7892D8DA899BB85193A8758A | Rating Details |
2022-08-24 17:18:28 -0500 | 0EA7F2F7EB85A0F33E9157CB3487AE228B3A3E746267753D0FE81E6F02CD217B | Rating Details |
2022-08-25 05:46:55 -0500 | 164CE44BAE6EC8080566AEC38C5DD185 | Rating Details |
2022-08-25 06:49:17 -0500 | 1B16E817D4B4C49CC9BE11FE50696836 | Rating Details |
2022-08-26 10:32:57 -0500 | 227B72516F48209D4CD398BD566B39A53B64980200BCA4A4C749072F49AA8384 | Rating Details |
2022-08-24 15:45:40 -0500 | 238938F8A35959DAFA9518817DEB65AA | Rating Details |
2022-08-30 03:18:14 -0500 | 2A6FF8BC4C90DBFED528285C0BA50A3D | Rating Details |
2022-08-24 19:36:41 -0500 | 38F3548DB0968885447F4DB82116D4277DCAC84BCA00434FF4A2AF27332D007E | Rating Details |
2022-08-24 18:08:37 -0500 | 39939FFCFCD913BFFFDD1D28202FCAF4548BDF9FD3D195BEC4E70706D24D51F1 | Rating Details |
2022-08-24 15:39:00 -0500 | 402B540523477342514CCBFB8666A02B089D96DD1F4F411E97879DB801B9D532 | Rating Details |
2022-08-24 17:37:15 -0500 | 4509441D75520EA35A35018BBB3EB650FE94C5F8B500D1CA82ADB724927D58D2 | Rating Details |
2022-08-24 20:00:22 -0500 | 491F86E495D57AD373CE546FA4D9E4C79AB3B56F4BD9907D2CD96BB4578540B1 | Rating Details |
2022-08-24 21:02:51 -0500 | 49226C36EDB5498392BFD9967E31AABE | Rating Details |
2022-08-24 19:17:24 -0500 | 51CF24E741A18508E181F80408E6E7E109FDDE98B31A9F11F05480731FF485A6 | Rating Details |
2022-10-04 15:25:24 -0500 | 53C1765ABC48486852D4F9EF5991D556 | Rating Details |
2022-08-24 15:39:00 -0500 | 582942164972653872F745BDA14A7E2C | Rating Details |
2022-08-24 19:17:24 -0500 | 5AD0B5581E4AC4683F4A8D75DEB62680 | Rating Details |
2022-08-24 16:50:29 -0500 | 6C4D39819380C974F26A34B6C85405BD | Rating Details |
2022-08-24 17:07:35 -0500 | 75DE5091E62053B99DD7EBEBFF9749047814415565DFD373C77AA987F69444BC | Rating Details |
2022-08-24 16:33:00 -0500 | 7B6C0F92F85A140EAA7D7FDA5011F64D198E4F2AA04B816CF947E32AE177B8D2 | Rating Details |
2022-08-24 14:56:16 -0500 | 80B440D82AFDE0B37332323C1A5E2FE37D810CDCF0CC78D348D1E1237BA2CE8F | Rating Details |
2022-08-24 17:07:35 -0500 | 84656258148090979F23255CE507BE9C | Rating Details |
2022-08-24 14:56:16 -0500 | 8BFAD8285CAFFD31C0DBA633F2C52E42 | Rating Details |
2022-08-24 17:18:28 -0500 | 8D92E46314F19B71C915156DEFA4A543 | Rating Details |
2022-08-24 15:45:40 -0500 | 9736DF42171A999208E640D9616E3AF1D2219C9694E38F806D374F891F58485E | Rating Details |
2022-08-24 18:08:37 -0500 | 9FC179459DAABBCED1F0FE580C206372 | Rating Details |
2022-08-24 16:50:29 -0500 | 9FDF9893DFAB4D45202E6558FAE3342DA24DFA5D58A9F7C14A2CF2DD79A3E176 | Rating Details |
2022-08-24 16:33:00 -0500 | A21BFCE289D6F7E96FF4749337E2DFF0 | Rating Details |
2022-08-24 14:45:15 -0500 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
2022-08-25 07:18:49 -0500 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
2022-08-24 19:36:41 -0500 | AC5368A3F99A3EA105D5DE64E5F3BF1D | Rating Details |
2022-08-26 10:32:57 -0500 | B47391ADD314142E98ADB1447C70FB98 | Rating Details |
2022-08-25 06:49:17 -0500 | C6932488574F7CBE3F1855D6C74B408F3BD254D3CD91A05D2E694BBC284B5C56 | Rating Details |
2022-08-24 14:51:10 -0500 | CD08C16BC8791D33E6EC9C8B27C91241 | Rating Details |
2022-08-24 20:00:22 -0500 | CD9D49DCCCDDE369B34482B66E49E224 | Rating Details |
2022-08-25 05:46:55 -0500 | CF92BDCE99BE54DA1B4908EF1CAE8AD3288902E489B6A71E370B824AAA2C3C95 | Rating Details |
2022-08-24 21:02:51 -0500 | CFB9899421B60B4A2A44EA9187BE4DF66FA7CBCC84660812C8E134C43B3A0B73 | Rating Details |
2022-08-24 14:46:53 -0500 | DA4507E4409ABAABB16D1F142ADEA36B | Rating Details |
2022-10-04 15:25:24 -0500 | E87EE2844723AF6921C9CB9520F13968D825D7359E96FB395389414B7368A681 | Rating Details |
2022-08-24 19:57:19 -0500 | F092EA4CB202B72F79AC43DE5CAF2DC7D60778EB0698DDEA8AB3EED4323C2245 | Rating Details |
2022-08-24 17:37:15 -0500 | F1E84256AB84F0D315EC9C221BF35F85 | Rating Details |
2022-08-30 03:18:14 -0500 | F59FC7DB0D407188B6133B7241DCA1D424AA62DB717409440635C8C398382A6D | Rating Details |
2022-08-24 19:57:19 -0500 | FBD4C539ADDD48521B69767302DD70B1 | Rating Details |
2022-08-24 17:37:15 -0500 | Rating Details | |
2022-08-24 14:46:53 -0500 | Rating Details | |
2022-08-24 15:39:00 -0500 | Rating Details | |
2022-08-25 05:46:55 -0500 | Rating Details | |
2022-08-24 21:02:51 -0500 | Rating Details | |
2022-08-24 15:45:40 -0500 | Rating Details | |
2022-08-25 07:18:49 -0500 | Rating Details | |
2022-08-24 14:56:16 -0500 | Rating Details | |
2022-08-24 20:00:22 -0500 | Rating Details | |
2022-08-25 06:49:17 -0500 | Rating Details | |
2022-08-24 19:36:41 -0500 | Rating Details | |
2022-08-24 16:50:29 -0500 | Rating Details | |
2022-08-24 14:51:10 -0500 | Rating Details | |
2022-08-24 17:18:28 -0500 | Rating Details | |
2022-08-24 14:45:15 -0500 | Rating Details | |
2022-08-30 03:18:14 -0500 | Rating Details | |
2022-08-24 19:17:24 -0500 | Rating Details | |
2022-10-04 15:25:24 -0500 | Rating Details | |
2022-08-24 16:33:00 -0500 | Rating Details | |
2022-08-26 10:32:57 -0500 | Rating Details | |
2022-08-24 17:07:35 -0500 | Rating Details |